Dystrobrevin, beta (DTNB) Peptide
-
- Target See all Dystrobrevin beta (DTNB) products
- Dystrobrevin beta (DTNB) (Dystrobrevin, beta (DTNB))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ASQPTPEKAQ QNPTLLAELR LLRQRKDELE QRMSALQESR RELMVQLEEL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DTNB antibody,
Alternative Names: DTNB control peptide, DTNB antibody Blocking Peptide, Anti-DTNB Blocking Peptide, Dystrobrevin Beta Blocking Peptide, MGC17163 Blocking Peptide, MGC57126 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Dystrobrevin beta (DTNB) (Dystrobrevin, beta (DTNB))
- Background
- DTNB is dystrobrevin beta, a component of the dystrophin-associated protein complex (DPC). The DPC consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and dystrobrevin alpha and beta. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Dystrobrevin beta is thought to interact with syntrophin and the DP71 short form of dystrophin.
- Molecular Weight
- 64 kDa
-